CZ:Ref:DOI:10.1097/BRS.0b013e3181c2a8b0: Difference between revisions
Jump to navigation
Jump to search
imported>Daniel Mietchen (started) |
imported>Daniel Mietchen (slight expansion) |
||
| Line 1: | Line 1: | ||
{{cite journal| author=Yang C, Hornicek FJ, Wood KB, Schwab JH, Choy E, Iafrate J et al.| title=Characterization and Analysis of Human Chordoma Cell Lines | journal=Spine (Phila Pa 1976) | year= 2010 | volume= | issue= | pages= | pmid=20461036 | {{cite journal| author=Yang C, Hornicek FJ, Wood KB, Schwab JH, Choy E, Iafrate J et al.| title=Characterization and Analysis of Human Chordoma Cell Lines | journal=Spine (Phila Pa 1976) | year= 2010 | volume= | issue= | pages= | pmid=20461036 | ||
| url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=clinical.uthscsa.edu/cite&retmode=ref&cmd=prlinks&id=20461036 | doi=10.1097/BRS.0b013e3181c2a8b0 }} | | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=clinical.uthscsa.edu/cite&retmode=ref&cmd=prlinks&id=20461036 | doi=10.1097/BRS.0b013e3181c2a8b0 }} | ||
:Describes three [[chordoma]] [[cell line]]s and found them to grow preferentially on [[collagen]] substrates, to retain the characteristic expression of [[vimentin]] and [[cytokeratin]] and to be sensitive to the [[chemotherapeutic]]s [[doxorubicin]], [[yondelis]], [[zalypsis]], and [[cisplatin]]. | :Describes three human [[chordoma]] [[cell line]]s and found them to grow preferentially on [[collagen]] substrates, to retain the characteristic expression of [[vimentin]] and [[cytokeratin]] and to be sensitive to the [[chemotherapeutic]]s [[doxorubicin]], [[yondelis]], [[zalypsis]], and [[cisplatin]]. | ||
Latest revision as of 08:06, 17 May 2010
Yang C, Hornicek FJ, Wood KB, Schwab JH, Choy E, Iafrate J et al. (2010). "Characterization and Analysis of Human Chordoma Cell Lines". Spine (Phila Pa 1976). DOI:10.1097/BRS.0b013e3181c2a8b0. PMID 20461036. Research Blogging. [e]
- Describes three human chordoma cell lines and found them to grow preferentially on collagen substrates, to retain the characteristic expression of vimentin and cytokeratin and to be sensitive to the chemotherapeutics doxorubicin, yondelis, zalypsis, and cisplatin.